RAMADAN INTERMITTENT FASTING IS ASSOCIATED WITH AMELIORATED INFLAMMATORY MARKERS AND IMPROVED PLASMA SPHINGOLIPIDS/CERAMIDES IN SUBJECTS WITH OBESITY: LIPIDOMICS ANALYSIS